Slide Stainer Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Equipment), By Technology (Cytology, Hematology) By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Slide Stainer Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Equipment), By Technology (Cytology, Hematology) By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030


Slide Stainer Market Size & Trends

The global slide stainer market size was estimated at USD 4.37 billion in 2023 and is projected to grow at a CAGR of 6.5% from 2024 to 2030. The market growth is attributed to the growing technological advancements in staining techniques, the increasing prevalence of chronic diseases requiring histological analysis, the growing demand for laboratory automation to improve efficiency and accuracy, and rising investments in healthcare infrastructure globally. According to the World Health Organization (WHO), the global burden of non-communicable diseases, such as cancer, cardiovascular diseases (CVDs), and diabetes, is on the rise, with these conditions accounting for over 70% of all deaths worldwide.

Advancements in staining technologies are also fuelling the market growth. Manufacturers continuously develop innovative staining techniques and reagents that offer improved staining quality, faster processing times, and enhanced compatibility with digital pathology workflows. For instance , in May 2022, Leica Biosystems launched its BOND-PRIME system, which features advanced staining algorithms and a user-friendly interface to streamline the process and improve diagnostic accuracy.

The growing demand for laboratory automation is driving the market growth. Automation streamlines laboratory workflows and reduces turnaround times for test results, improving patient care outcomes. For instance, in November 2023, an article published under the title Cutting-edge Offering and Automation in the Pathology Laboratory stated that adopting automated slide stainers in pathology laboratories has been shown to reduce turnaround times by up to 50% and improve the consistency of staining results.

In addition, the accuracy and consistency of test results and the reduction of laboratory workload have been achieved with automatic and digital slide-staining equipment, which has completely changed how laboratories work. The rapid digitization of imaging methods has led to a greater economy and efficiency in laboratory setups. Glasses can be scanned and digitized with digital slide scanners, allowing medical professionals to collaborate and view data remotely. Laboratory setups are more productive and efficient, and diagnoses are made faster and more accurately. Another technological advancement is the development of new staining methods, such as multiple staining, which allows multiple antigens to be stained on a single slide.

However, rapid technological advancements and innovations are some of the major challenges faced by the market. To remain competitive, manufacturers constantly focus on updating and improving their products as technology advances. This requires large investments in research and development and creates a significant financial burden. Moreover, stainers are subject to strict health regulations, further restraining the market's growth.

Global Slide Stainer Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global slide stainer market report based on product, technology, application, end-use, and region;
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Reagents & Kits
  • Stains
  • Diluents & Buffers
  • Blocking Sera & Reagents
  • Mounting Media, Fixative Reagents, and Embedded Media
  • Probes
  • Antibodies
  • Equipment
  • Automated and Semi-automated Slide Stainer
  • Manual Staining Set
  • Consumables & Accessories
  • Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Hematoxylin and Eosin
  • Immunohistochemistry
  • Cytology
  • Microbiology
  • Special Stains
  • In-situ Hybridization
  • Hematology
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Disease Diagnostics
  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-small Lung Cancer
  • Other Application
  • Medical Research
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals and Diagnostics Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Other End-users
  • Regional Outlook (Revenue in USD Million, 2018 - 2030)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Technology outlook
2.2.3. Application outlook
2.2.4. End Use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Slide Stainer Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements
3.2.1.2. Increasing prevalence of chronic diseases
3.2.1.3. The growing demand for laboratory automation
3.2.2. Market restraint analysis
3.2.2.1. High costs of slide stainer
3.3. Slide Stainer Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Slide Stainer Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Slide Stainer Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Reagents & Kits
4.4.1.1. Reagents & kits market estimates and forecasts 2018 - 2030 (USD Million)
4.4.1.2. Stains
4.4.1.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.1.3. Diluents & Buffers
4.4.1.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.1.4. Blocking Sera & Reagents
4.4.1.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.1.5. Mounting Media, Fixative Reagents, and Embedded Media
4.4.1.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.1.6. Probes
4.4.1.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.1.7. Antibodies
4.4.1.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Equipment
4.4.2.1. Equipment market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2.2. Automated and Semi-automated Slide Stainer
4.4.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2.2.2. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2.3. Manual Staining Set
4.4.3. Consumables & Accessories
4.4.3.1. Consumables & accessories market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 5. Slide Stainer Market: Technology Estimates & Trend Analysis
5.1. Technology Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Slide Stainer Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hematoxylin and Eosin
5.4.1.1. Hematoxylin and Eosin market estimates and forecasts 2018 - 2030 (USD Million)
5.4.2. Immunohistochemistry
5.4.2.1. Immunohistochemistry market estimates and forecasts 2018 - 2030 (USD Million)
5.4.3. Cytology
5.4.3.1. Cytology market estimates and forecasts 2018 - 2030 (USD Million)
5.4.4. Microbiology
5.4.4.1. Microbiology market estimates and forecasts 2018 - 2030 (USD Million)
5.4.5. Special Stains
5.4.5.1. Special stains market estimates and forecasts 2018 - 2030 (USD Million)
5.4.6. In-situ Hybridization
5.4.6.1. In-situ hybridization market estimates and forecasts 2018 - 2030 (USD Million)
5.4.7. Hematology
5.4.7.1. Hematology market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 6. Slide Stainer Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Slide Stainer Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Disease Diagnostics
6.4.1.1. Disease diagnostics market estimates and forecasts 2018 - 2030 (USD Million)
6.4.1.2. Breast Cancer
6.4.1.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.4.1.3. Gastric Cancer
6.4.1.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.4.1.4. Lymphoma
6.4.1.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.4.1.5. Prostate Cancer
6.4.1.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.4.1.6. Non-small Lung Cancer
6.4.1.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.4.1.7. Other Application
6.4.1.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.4.2. Medical Research
6.4.2.1. Medical research market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 7. Slide Stainer Market: End Use Estimates & Trend Analysis
7.1. End Use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Slide Stainer Market by End Use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Hospitals and Diagnostics Laboratories
7.4.1.1. Hospitals and diagnostics laboratories market estimates and forecasts 2018 - 2030 (USD Million)
7.4.2. Academic & Research Institutes
7.4.2.1. Academic & research institutes market estimates and forecasts 2018 - 2030 (USD Million)
7.4.3. Pharmaceutical & Biotechnology Companies
7.4.3.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 - 2030 (USD Million)
7.4.4. Other End Users
7.4.4.1. Other end users market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 8. Slide Stainer Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. North America
8.5.2. U.S.
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
8.5.3. Canada
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
8.5.4. Mexico
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
8.6. Europe
8.6.1. Europe
8.6.2. UK
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ Reimbursement
8.6.2.3. Competitive scenario
8.6.2.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
8.6.3. Germany
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ Reimbursement
8.6.3.3. Competitive scenario
8.6.3.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
8.6.4. France
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/ Reimbursement
8.6.4.3. Competitive scenario
8.6.4.4. France market estimates and forecasts 2018 - 2030 (USD Million)
8.6.5. Italy
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/ Reimbursement
8.6.5.3. Competitive scenario
8.6.5.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
8.6.6. Spain
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
8.6.7. Denmark
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework/ Reimbursement
8.6.7.3. Competitive scenario
8.6.7.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
8.6.8. Sweden
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework
8.6.8.3. Competitive scenario
8.6.8.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
8.6.9. Norway
8.6.9.1. Key country dynamics
8.6.9.2. Regulatory framework
8.6.9.3. Competitive scenario
8.6.9.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Asia Pacific
8.7.2. Japan
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ Reimbursement
8.7.2.3. Competitive scenario
8.7.2.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
8.7.3. China
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ Reimbursement
8.7.3.3. Competitive scenario
8.7.3.4. China market estimates and forecasts 2018 - 2030 (USD Million)
8.7.4. India
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ Reimbursement
8.7.4.3. Competitive scenario
8.7.4.4. India market estimates and forecasts 2018 - 2030 (USD Million)
8.7.5. Australia
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework/ Reimbursement
8.7.5.3. Competitive scenario
8.7.5.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
8.7.6. South Korea
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework/ Reimbursement
8.7.6.3. Competitive scenario
8.7.6.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
8.7.7. Thailand
8.7.7.1. Key country dynamics
8.7.7.2. Regulatory framework/ Reimbursement
8.7.7.3. Competitive scenario
8.7.7.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
8.8. Latin America
8.8.1. Latin America
8.8.2. Brazil
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
8.8.3. Argentina
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework/ Reimbursement
8.8.3.3. Competitive scenario
8.8.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
8.9. MEA
8.9.1. MEA
8.9.2. South Africa
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework/ Reimbursement
8.9.2.3. Competitive scenario
8.9.2.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework/ Reimbursement
8.9.3.3. Competitive scenario
8.9.3.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
8.9.4. UAE
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework/ Reimbursement
8.9.4.3. Competitive scenario
8.9.4.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
8.9.5. Kuwait
8.9.5.1. Key country dynamics
8.9.5.2. Regulatory framework
8.9.5.3. Competitive scenario
8.9.5.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Thermo Fisher Scientific, Inc.
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Others benchmarking
9.3.4.4. Strategic initiatives
9.3.5. F Hoffmann-La Roche Ltd
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Others benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Danaher Corporation
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Others benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Merck KGaA
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Others benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Agilent Technologies, Inc.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Others benchmarking
9.3.8.4. Strategic initiatives
9.3.9. BD (Becton, Dickinson and Company)
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Others benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Abcam Limited
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Others benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Siemens Healthineers AG
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Others benchmarking
9.3.11.4. Strategic initiatives
9.3.12. General Data Company, Inc.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Others benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Biocare Medical, LLC
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Others benchmarking
9.3.13.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings